Adverse events50

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

41 to 50 of 50

Type	Event	Organ system	Group	Affected	At risk
other	Posterior capsule opacification	Eye disorders	QR-110 Low Dose	0	6
other	Posterior capsule opacification	Eye disorders	QR-110 Mid Dose	1	5
other	Retinal cyst	Eye disorders	QR-110 Low Dose	0	6
other	Retinal cyst	Eye disorders	QR-110 Mid Dose	1	5
other	Vitreal cells	Eye disorders	QR-110 Low Dose	0	6
other	Vitreal cells	Eye disorders	QR-110 Mid Dose	1	5
other	Vitreous opacities	Eye disorders	QR-110 Low Dose	0	6
other	Vitreous opacities	Eye disorders	QR-110 Mid Dose	1	5
serious	Cataract	Eye disorders	QR-110 Low Dose	2	6
serious	Cataract	Eye disorders	QR-110 Mid Dose	4	5

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03140969/events?page=3